Cargando…
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of international concern” (PHEIC). The infection is highly contagious, has a high mortality rate, and its pathophysiology remains poorly...
Autores principales: | Mohamed Khosroshahi, Leila, Rokni, Mohsen, Mokhtari, Tahmineh, Noorbakhsh, Farshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784533/ https://www.ncbi.nlm.nih.gov/pubmed/33486333 http://dx.doi.org/10.1016/j.intimp.2020.107364 |
Ejemplares similares
-
COVID-19: immunopathogenesis and Immunotherapeutics
por: Yang, Li, et al.
Publicado: (2020) -
Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics
por: Ebrahimi, Negin, et al.
Publicado: (2020) -
Sarcoidosis: Immunopathogenesis and Immunological Markers
por: Loke, Wei Sheng Joshua, et al.
Publicado: (2013) -
Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases
por: Sadeghi Shaker, Mina, et al.
Publicado: (2023) -
Editorial: Immunology and immunopathogenesis of human leishmaniasis
por: de Menezes, Juliana P. B., et al.
Publicado: (2022)